48% of Canadians with severe allergies risk their lives by not carrying their epinephrine auto-injector (EAI). Why? For 40 years, the only option (EpiPen) was indiscreet and confusing to use. To dismantle this ‘EpiPen reflex,’ ALLERJECT focused on its innovation in portable size, voice instructions and auto-retractable needle. In the first three months, the ‘Fits Your Life’ integrated launch campaign stole 10% market share and launched a new behaviour: actually carrying their EAI.
Awards
Silver Echo
